MÉTABOLITE ANTAGONISTE DU RÉCEPTEUR DE L'ANGIOTENSINE II ET COMPOSITE INHIBITEUR DE LA NEP, ET PROCÉDÉ DE PRÉPARATION ASSOCIÉ
- 专利权人:
- Ltd;Shenzhen Salubris Pharmaceuticals Co.
- 发明人:
- 申请号：
- EP17741062.8
- 公开号：
- EP3406610A4
- 申请日:
- 2017.01.19
- 申请国别(地区):
- EP
- 年份:
- 2019
- 代理人:
- 摘要：
- A series of supermolecular complexes (compounds) with dual-acting are provided in this invention which are composed of the compound with angiotensin II receptor (ATI) blocking effect, neprilysin inhibitor (NEPi), and pharmaceutically acceptable cations thereof.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- MÉTABOLITE ANTAGONISTE DU RÉCEPTEUR DE L'ANGIOTENSINE II ET COMPOSITE INHIBITEUR DE LA NEP, ET PROCÉDÉ DE PRÉPARATION ASSOCIÉ
- Dual-acting benzyl triazole antihypertensive agents having angiotensin II type receptor antagonist activity and neprilysin-inhibition activity
- Intermediates for preparing dual-acting benzyl triazole antihypertensive agents having angiotensin II type I receptor antagonist activity and neprilysin-inhibition activity
- DUAL-ACTING ANTIHYPERTENSIVE AGENTS
- Stimulant and / or activator of soluble guanylate cyclase (sGC) in combination with an inhibitor of neutral endopeptidase (NEP inhibitor) and / or an angiotensin II antagonist and use thereof
